Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Cancer Res. 2016 Apr 1;76(11):3189–3199. doi: 10.1158/0008-5472.CAN-15-2840

Table 1.

Clinicopathological information of the lung adenocarcinoma PROSPECT set used for STAT3 mRNA analysis

Covariate Covariate categories Frequency (percentage)
Race African American 8 (5.3%)
Asian 6 (4.0%)
Hispanic 5 (3.3%)
Caucasian 131 (87.3%)
Tobacco history No 19 (12.7%)
Yes 131 (87.3%)
Smoking status Never 19 (12.7%)
Former 67 (44.7%)
Current 64 (42.6%)
Gender Female 73 (48.7%)
Male 77 (51.3%)
Stage I 90 (60.0%)
II 24 (16.0%)
III 35 (23.3%)
IV 1 (0.7%)
KRAS Wild type 111 (74.0%)
Mutant 39 (26.0%)
Recurrence No 89 (59.3%)
Yes 61 (40.7%)